We live in exciting times for adherence, and the pharma industry is playing a critical role, according to Mark Degatano, a pharmaceutical industry analytics expert who is on the advisory board of AllazoHealth. Degatano’s expertise…
Read more
Eli Lilly and Co. and Abbott have made headlines recently for using real-world evidence to prove better adherence and outcomes for its diabetes products. More pharma companies are likely to utilize real-world data to support…
Read more
Payers, pharmacies and pharmaceutical companies are starting to join providers in recognizing that social determinants of health (SDOH) have a major impact on patient adherence and clinical outcomes. Healthcare organizations now face the challenge of…
Read more
With medication non-adherence costing the industry more than $600 billion a year, many pharmaceutical companies are creating medication adherence programs, often in conjunction with pharmacists and payers. According to Andrea Kasprzyk, Director of Sales at…
Read more
As common as artificial intelligence has become in our daily lives — from Google’s Alexa, to Facebook’s data-driven ads, to Waze’s application of driver data to find the best route — it is little understood.…
Read more
AllazoHealth, a company that uses artificial intelligence (AI) to help enterprise healthcare companies improve medication adherence and quality outcomes, has released a new study demonstrating the impact of AI on patient adherence indicators. The poster…
Read more
Many healthcare organizations are turning to artificial intelligence to uplift patient adherence. And these organizations are all asking the same question: buy it, or build it? It’s very natural for organization leadership to say, “Hey,…
Read more
A leading pharmaceutical company engaged AllazoHealth on a multi-year project using artificial intelligence to optimize a patient support program for a major product. Overcoming an adherence challenge The pharmaceutical company faced a challenge: An estimated…
Read more
Pharmacies can use artificial intelligence to make adherence improvements that meet the goals of their payer contracts, specifically the ones known as DIR (direct and indirect remuneration). When it comes to getting reimbursements, adherence plays…
Read more